Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-22

Clinical Trial Update: Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating sintilimab in combination with chemotherapy and radiotherapy for patients with inoperable pancreatic cancer and is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sintilimab (sintilimab)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Pancreas Cancer | Phase 2 | Status: RECRUITING